Mainstreaming genetic counseling for BRCA testing into oncology clinics - Indian perspective
BReastCAncer (BRCA) susceptibility genes BRCA1 and BRCA2 are mainly associated with hereditary breast and ovarian cancer (HBOC) syndrome and present an estimated 45%-65% cumulative lifetime risk of developing breast cancer and an 11%-39% risk of ovarian cancer. HBOC is also linked to triple-negative...
Gespeichert in:
| Veröffentlicht in: | Indian journal of cancer 2019-11, Vol.56 (5), p.38-47 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 47 |
|---|---|
| container_issue | 5 |
| container_start_page | 38 |
| container_title | Indian journal of cancer |
| container_volume | 56 |
| creator | Verma, Amit Nag, Shona Hasan, Qurratulain Selvakumar, Veda |
| description | BReastCAncer (BRCA) susceptibility genes BRCA1 and BRCA2 are mainly associated with hereditary breast and ovarian cancer (HBOC) syndrome and present an estimated 45%-65% cumulative lifetime risk of developing breast cancer and an 11%-39% risk of ovarian cancer. HBOC is also linked to triple-negative breast cancer (TNBC). BRCA1 mutations in TNBC are observed in 36% of women age |
| doi_str_mv | 10.4103/ijc.IJC_458_19 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2320934395</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2320934395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379e-dc287830c4bd4d554e5ae0b3727490d5e1f51c3a6f976c1a4d5f794fe39d82273</originalsourceid><addsrcrecordid>eNp1kE1LAzEURYMotla3LiXgemoyyTSTldTiR6UiiIILIUwzb0raaVKTGUv_vSmtunIVeJx3X-5B6JySPqeEXZm57o8fR4pnuaLyAHWplHnCheCHqEsIlUlG5HsHnYQwJyRlKc-PUYdRIRnntIs-ngpjQ-OhWBo7wzOw0BiNtWttgHo7qpzHNy-jIW4gNNuBsY3DzmpXu9kG6wgZHXCCx7Y0hcUr8GEFujFfcIqOqqIOcLZ_e-jt7vZ19JBMnu_Ho-Ek0UxISEqd5iJnRPNpycss45AVQKZMpIJLUmZAq4xqVgwqKQaaFpGphOQVMFnmaSpYD13uclfefbbxm2ruWm_jSRUbk1iVySxS_R2lvQvBQ6VW3iwLv1GUqK1MFWWqP5lx4WIf206XUP7iP_YicL0D1q5uYu1F3a7Bq8gurFv_E6tYrn6ks29_Xob6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2320934395</pqid></control><display><type>article</type><title>Mainstreaming genetic counseling for BRCA testing into oncology clinics - Indian perspective</title><source>Medknow Open Access Medical Journals(OpenAccess)</source><source>MEDLINE</source><source>Bioline International</source><source>Free E-Journal (出版社公開部分のみ）</source><creator>Verma, Amit ; Nag, Shona ; Hasan, Qurratulain ; Selvakumar, Veda</creator><creatorcontrib>Verma, Amit ; Nag, Shona ; Hasan, Qurratulain ; Selvakumar, Veda</creatorcontrib><description>BReastCAncer (BRCA) susceptibility genes BRCA1 and BRCA2 are mainly associated with hereditary breast and ovarian cancer (HBOC) syndrome and present an estimated 45%-65% cumulative lifetime risk of developing breast cancer and an 11%-39% risk of ovarian cancer. HBOC is also linked to triple-negative breast cancer (TNBC). BRCA1 mutations in TNBC are observed in 36% of women age <40 years and 27% of women age <50 years. In India, the prevalence of BRCA1/2 mutation varies from 2.9% to 38% among families with genetic predisposition toward hereditary cancers. With HBOC being linked to early-onset breast cancer and increased susceptibility to other cancers, early screening for BRCA mutations has become a pressing need. Though genetic counseling (GC) for BRCA mutation testing is common in most of the developed countries, India still faces several challenges in mainstreaming the same. Many barriers to effective GC for BRCA testing are unique to India. There is a dearth of trained geneticists which puts the pressure on oncologists to give GC for which they neither have the time or training. Presence of multiethnic/linguistic population acts as a major hindrance along the way toward development of robust predictive and effective GC models for BRCA testing. The current review discusses the need and benefits of GC in breast cancer prevention, through BRCA testing, from an Indian perspective. The functional framework of GC and the role of genetic counselors are discussed in detail. In addition, importance of GC training and role of a multidisciplinary team approach for mainstreaming pre- and post-BRCA test GC is highlighted.</description><identifier>ISSN: 0019-509X</identifier><identifier>EISSN: 1998-4774</identifier><identifier>DOI: 10.4103/ijc.IJC_458_19</identifier><identifier>PMID: 31793441</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>BRCA2 Protein - genetics ; Breast cancer ; Family medical history ; Female ; Genetic Counseling - methods ; Health risk assessment ; Humans ; India ; Male ; Middle Aged ; Mutation ; Ovarian cancer</subject><ispartof>Indian journal of cancer, 2019-11, Vol.56 (5), p.38-47</ispartof><rights>2019. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379e-dc287830c4bd4d554e5ae0b3727490d5e1f51c3a6f976c1a4d5f794fe39d82273</citedby><cites>FETCH-LOGICAL-c379e-dc287830c4bd4d554e5ae0b3727490d5e1f51c3a6f976c1a4d5f794fe39d82273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27458,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31793441$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verma, Amit</creatorcontrib><creatorcontrib>Nag, Shona</creatorcontrib><creatorcontrib>Hasan, Qurratulain</creatorcontrib><creatorcontrib>Selvakumar, Veda</creatorcontrib><title>Mainstreaming genetic counseling for BRCA testing into oncology clinics - Indian perspective</title><title>Indian journal of cancer</title><addtitle>Indian J Cancer</addtitle><description>BReastCAncer (BRCA) susceptibility genes BRCA1 and BRCA2 are mainly associated with hereditary breast and ovarian cancer (HBOC) syndrome and present an estimated 45%-65% cumulative lifetime risk of developing breast cancer and an 11%-39% risk of ovarian cancer. HBOC is also linked to triple-negative breast cancer (TNBC). BRCA1 mutations in TNBC are observed in 36% of women age <40 years and 27% of women age <50 years. In India, the prevalence of BRCA1/2 mutation varies from 2.9% to 38% among families with genetic predisposition toward hereditary cancers. With HBOC being linked to early-onset breast cancer and increased susceptibility to other cancers, early screening for BRCA mutations has become a pressing need. Though genetic counseling (GC) for BRCA mutation testing is common in most of the developed countries, India still faces several challenges in mainstreaming the same. Many barriers to effective GC for BRCA testing are unique to India. There is a dearth of trained geneticists which puts the pressure on oncologists to give GC for which they neither have the time or training. Presence of multiethnic/linguistic population acts as a major hindrance along the way toward development of robust predictive and effective GC models for BRCA testing. The current review discusses the need and benefits of GC in breast cancer prevention, through BRCA testing, from an Indian perspective. The functional framework of GC and the role of genetic counselors are discussed in detail. In addition, importance of GC training and role of a multidisciplinary team approach for mainstreaming pre- and post-BRCA test GC is highlighted.</description><subject>BRCA2 Protein - genetics</subject><subject>Breast cancer</subject><subject>Family medical history</subject><subject>Female</subject><subject>Genetic Counseling - methods</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>India</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Ovarian cancer</subject><issn>0019-509X</issn><issn>1998-4774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kE1LAzEURYMotla3LiXgemoyyTSTldTiR6UiiIILIUwzb0raaVKTGUv_vSmtunIVeJx3X-5B6JySPqeEXZm57o8fR4pnuaLyAHWplHnCheCHqEsIlUlG5HsHnYQwJyRlKc-PUYdRIRnntIs-ngpjQ-OhWBo7wzOw0BiNtWttgHo7qpzHNy-jIW4gNNuBsY3DzmpXu9kG6wgZHXCCx7Y0hcUr8GEFujFfcIqOqqIOcLZ_e-jt7vZ19JBMnu_Ho-Ek0UxISEqd5iJnRPNpycss45AVQKZMpIJLUmZAq4xqVgwqKQaaFpGphOQVMFnmaSpYD13uclfefbbxm2ruWm_jSRUbk1iVySxS_R2lvQvBQ6VW3iwLv1GUqK1MFWWqP5lx4WIf206XUP7iP_YicL0D1q5uYu1F3a7Bq8gurFv_E6tYrn6ks29_Xob6</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Verma, Amit</creator><creator>Nag, Shona</creator><creator>Hasan, Qurratulain</creator><creator>Selvakumar, Veda</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20191101</creationdate><title>Mainstreaming genetic counseling for BRCA testing into oncology clinics - Indian perspective</title><author>Verma, Amit ; Nag, Shona ; Hasan, Qurratulain ; Selvakumar, Veda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379e-dc287830c4bd4d554e5ae0b3727490d5e1f51c3a6f976c1a4d5f794fe39d82273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>BRCA2 Protein - genetics</topic><topic>Breast cancer</topic><topic>Family medical history</topic><topic>Female</topic><topic>Genetic Counseling - methods</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>India</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Ovarian cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verma, Amit</creatorcontrib><creatorcontrib>Nag, Shona</creatorcontrib><creatorcontrib>Hasan, Qurratulain</creatorcontrib><creatorcontrib>Selvakumar, Veda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Indian journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verma, Amit</au><au>Nag, Shona</au><au>Hasan, Qurratulain</au><au>Selvakumar, Veda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mainstreaming genetic counseling for BRCA testing into oncology clinics - Indian perspective</atitle><jtitle>Indian journal of cancer</jtitle><addtitle>Indian J Cancer</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>56</volume><issue>5</issue><spage>38</spage><epage>47</epage><pages>38-47</pages><issn>0019-509X</issn><eissn>1998-4774</eissn><abstract>BReastCAncer (BRCA) susceptibility genes BRCA1 and BRCA2 are mainly associated with hereditary breast and ovarian cancer (HBOC) syndrome and present an estimated 45%-65% cumulative lifetime risk of developing breast cancer and an 11%-39% risk of ovarian cancer. HBOC is also linked to triple-negative breast cancer (TNBC). BRCA1 mutations in TNBC are observed in 36% of women age <40 years and 27% of women age <50 years. In India, the prevalence of BRCA1/2 mutation varies from 2.9% to 38% among families with genetic predisposition toward hereditary cancers. With HBOC being linked to early-onset breast cancer and increased susceptibility to other cancers, early screening for BRCA mutations has become a pressing need. Though genetic counseling (GC) for BRCA mutation testing is common in most of the developed countries, India still faces several challenges in mainstreaming the same. Many barriers to effective GC for BRCA testing are unique to India. There is a dearth of trained geneticists which puts the pressure on oncologists to give GC for which they neither have the time or training. Presence of multiethnic/linguistic population acts as a major hindrance along the way toward development of robust predictive and effective GC models for BRCA testing. The current review discusses the need and benefits of GC in breast cancer prevention, through BRCA testing, from an Indian perspective. The functional framework of GC and the role of genetic counselors are discussed in detail. In addition, importance of GC training and role of a multidisciplinary team approach for mainstreaming pre- and post-BRCA test GC is highlighted.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>31793441</pmid><doi>10.4103/ijc.IJC_458_19</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0019-509X |
| ispartof | Indian journal of cancer, 2019-11, Vol.56 (5), p.38-47 |
| issn | 0019-509X 1998-4774 |
| language | eng |
| recordid | cdi_proquest_journals_2320934395 |
| source | Medknow Open Access Medical Journals(OpenAccess); MEDLINE; Bioline International; Free E-Journal (出版社公開部分のみ） |
| subjects | BRCA2 Protein - genetics Breast cancer Family medical history Female Genetic Counseling - methods Health risk assessment Humans India Male Middle Aged Mutation Ovarian cancer |
| title | Mainstreaming genetic counseling for BRCA testing into oncology clinics - Indian perspective |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T07%3A50%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mainstreaming%20genetic%20counseling%20for%20BRCA%20testing%20into%20oncology%20clinics%20-%20Indian%20perspective&rft.jtitle=Indian%20journal%20of%20cancer&rft.au=Verma,%20Amit&rft.date=2019-11-01&rft.volume=56&rft.issue=5&rft.spage=38&rft.epage=47&rft.pages=38-47&rft.issn=0019-509X&rft.eissn=1998-4774&rft_id=info:doi/10.4103/ijc.IJC_458_19&rft_dat=%3Cproquest_cross%3E2320934395%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2320934395&rft_id=info:pmid/31793441&rfr_iscdi=true |